CHLORPROMAZINE HYDROCHLORIDE (CHLORPROMAZINE HYDROCHLORIDE)
Pending LLM rewrite. Source: FDA_DRUG D-0637-2025.
Severity not yet assessed
We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.
Plain-English summary
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
The recalled product
- Product
- CHLORPROMAZINE HYDROCHLORIDE (CHLORPROMAZINE HYDROCHLORIDE)
- Brand
- CHLORPROMAZINE HYDROCHLORIDE
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: Z305456
- Exp Date 31-10-25
- Z401156
- Exp Date 28-02-26
- Z407306
- Exp Date 30-11-26
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CHLORPROMAZINE HYDROCHLORIDE
- ModerateChlorpromazine Hydrochloride Tablets Recalled Due to Impurity
FDA (Drugs) · 2025-04-23
- SevereChlorpromazine Hydrochloride Tablets Recalled Due to Impurity
FDA (Drugs) · 2025-04-16
- ModeratePrescription Antipsychotic Drug Recalled for Manufacturing Impurity
FDA (Drugs) · 2025-04-09
- HighChlorpromazine Hydrochloride tablets recalled for manufacturing impurity excess
FDA (Drugs) · 2025-01-01
- HighPrescription chlorpromazine tablets recalled due to manufacturing quality defect
FDA (Drugs) · 2025-01-01
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22